Results of a multinational study suggests rapid diagnosis and early onset of antiviral treatment in herpetic meningoencephalitis
Hakan Erdem
,
Yasemin Cag
,
Derya Ozturk-Engin
,
Sylviane Defres
,
Selcuk Kaya
,
Lykke Larsen
,
Mario Poljak
(1)
,
Bruno Barsic
,
Xavier Argemi
,
Signe Maj Sørensen
,
Anne Lisbeth Bohr
,
Pierre Tattevin
(2, 3)
,
Jesper Damsgaard Gunst
,
Lenka Baštáková
,
Matjaž Jereb
,
Isik Somuncu Johansen
,
Oguz Karabay
,
Abdullah Umut Pekok
,
Oguz Resat Sipahi
,
Mahtab Chehri
,
Guillaume Beraud
,
Ghaydaa Shehata
,
Rosa Fontana del Vecchio
,
Mauro Maresca
,
Hasan Karsen
,
Gonul Sengoz
,
Mustafa Sunbul
,
Gulden Yilmaz
,
Hava Yilmaz
,
Ahmad Sharif-Yakan
,
Souha Kanj
,
Emine Parlak
,
Filiz Pehlivanoglu
,
Fatime Korkmaz
,
Suheyla Komur
,
Sukran Kose
,
Mehmet Ulug
,
Sibel Bolukcu
,
Seher Ayten Coskuner
,
Nevin Ince
,
Yasemin Akkoyunlu
,
Gulistan Halac
,
Elif Sahin-Horasan
,
Hulya Tireli
,
Gamze Kilicoglu
,
Akram Al-Mahdawi
,
Salih Atakan Nemli
,
Asuman Inan
,
Seniha Senbayrak
,
Jean Paul Stahl
,
Haluk Vahaboglu
Hakan Erdem
- Function : Author
Yasemin Cag
- Function : Author
Derya Ozturk-Engin
- Function : Author
Sylviane Defres
- Function : Author
Selcuk Kaya
- Function : Author
Lykke Larsen
- Function : Author
Mario Poljak
- Function : Author
- PersonId : 906210
Bruno Barsic
- Function : Author
Xavier Argemi
- Function : Author
Signe Maj Sørensen
- Function : Author
Anne Lisbeth Bohr
- Function : Author
Pierre Tattevin
- Function : Author
- PersonId : 756765
- ORCID : 0000-0003-3617-5411
- IdRef : 057598207
Jesper Damsgaard Gunst
- Function : Author
Lenka Baštáková
- Function : Author
Matjaž Jereb
- Function : Author
Isik Somuncu Johansen
- Function : Author
Oguz Karabay
- Function : Author
Abdullah Umut Pekok
- Function : Author
Oguz Resat Sipahi
- Function : Author
Mahtab Chehri
- Function : Author
Guillaume Beraud
- Function : Author
- PersonId : 773976
- IdHAL : guillaume-beraud
- ORCID : 0000-0002-4705-0916
- IdRef : 113639562
Ghaydaa Shehata
- Function : Author
Rosa Fontana del Vecchio
- Function : Author
Mauro Maresca
- Function : Author
Hasan Karsen
- Function : Author
Gonul Sengoz
- Function : Author
Mustafa Sunbul
- Function : Author
Gulden Yilmaz
- Function : Author
Hava Yilmaz
- Function : Author
Ahmad Sharif-Yakan
- Function : Author
Souha Kanj
- Function : Author
Emine Parlak
- Function : Author
Filiz Pehlivanoglu
- Function : Author
Fatime Korkmaz
- Function : Author
Suheyla Komur
- Function : Author
Sukran Kose
- Function : Author
Mehmet Ulug
- Function : Author
Sibel Bolukcu
- Function : Author
Seher Ayten Coskuner
- Function : Author
Nevin Ince
- Function : Author
Yasemin Akkoyunlu
- Function : Author
Gulistan Halac
- Function : Author
Elif Sahin-Horasan
- Function : Author
Hulya Tireli
- Function : Author
Gamze Kilicoglu
- Function : Author
Akram Al-Mahdawi
- Function : Author
Salih Atakan Nemli
- Function : Author
Asuman Inan
- Function : Author
Seniha Senbayrak
- Function : Author
Jean Paul Stahl
- Function : Author
Haluk Vahaboglu
- Function : Author
Abstract
Data in the literature regarding the factors that predict unfavorable outcomes in adult herpetic meningoencephalitis (HME) cases are scarce. We conducted a multicenter study in order to provide insights into the predictors of HME outcomes, with special emphasis on the use and timing of antiviral treatment. Samples from 501 patients with molecular confirmation from cerebrospinal fluid were included from 35 referral centers in 10 countries. Four hundred thirty-eight patients were found to be eligible for the analysis. Overall, 232 (52.9%) patients experienced unfavorable outcomes, 44 died, and 188 survived, with sequelae. Age (odds ratio [OR], 1.04; 95% confidence interval [CI], 1.02 to 1.05), Glasgow Coma Scale score (OR, 0.84; 95% CI, 0.77 to 0.93), and symptomatic periods of 2 to 7 days (OR, 1.80; 95% CI, 1.16 to 2.79) and >7 days (OR, 3.75; 95% CI, 1.72 to 8.15) until the commencement of treatment predicted unfavorable outcomes. The outcome in HME patients is related to a combination of therapeutic and host factors. This study suggests that rapid diagnosis and early administration of antiviral treatment in HME patients are keys to a favorable outcome.